The synergistic interaction between morphine and maprotiline after intrathecal injection in rats.

Full Abstract

BACKGROUND: Antidepressant drugs act as potent inhibitors of norepinephrine and/or serotonin reuptake and are widely used with opioids for the treatment of chronic pain. The mechanism of this increased analgesic action is unclear. We compared the antinociceptive effects of the intrathecal administration of morphine with that of a nonselective (amitriptyline) or selective (maprotiline or citalopram) antidepressant drug using the thermal withdrawal test in rats. We also investigated the possible mechanisms involved in the interactions of these drugs. METHODS: Male Wistar rats were anesthetized with sevoflurane and administered morphine and antidepressant drugs, or saline, through intrathecal injection. The antinociceptive effect was evaluated using the thermal withdrawal test before and after drug administration. The time for the withdrawal reaction was expressed as percentage of maximum possible effect (MPE). Animals were also pretreated with yohimbine (a nonselective alpha2-adrenergic antagonist) and naloxone (a nonselective opioid antagonist) for mechanism of action studies. Pharmacologic interaction was evaluated using isobolographic analysis of simultaneous administration of fixed proportions of maprotiline and morphine. RESULTS: Single intrathecal administration of morphine (2 microg), amitriptiline (125 microg), citalopram (144 microg), and maprotiline (1.25 microg) produced 51.6% +/- 8.9%, 10.3% +/- 3.2%, 33.8% +/- 5.2%, and 48.5% +/- 9.2% MPE, respectively. The antinociceptive effect of morphine was increased when combined with amitriptyline (91.3% +/- 4.6% MPE) and maprotiline (86.9% +/- 9.2% MPE) but not with citalopram (40.6% +/- 4.6% MPE). Coadministration of maprotiline increased the antinociceptive duration of morphine by 4-fold (from 120 to 480 min), which was reversed by pretreatment with the alpha-2 adrenoceptor inhibitor, yohimbine, and the mu-type opioid receptor antagonist, naloxone. Isobolographic analysis demonstrated a synergistic interaction between morphine and maprotiline. CONCLUSIONS: Selective norepinephrine reuptake inhibitors can significantly increase the intensity and duration of morphine antinociceptive activity via both alpha(2)-adrenergic and opioid receptors. This interaction was not observed with the selective serotonin inhibitor, citalopram.

Author information

Author/s: Pettersen, Vera L A (VL); Zapata-Sudo, Gisele (G); Raimundo, Juliana M (JM); Trachez, Margarete M (MM); Sudo, Roberto T (RT);

Affiliation: Programa de Pós-Graduação em Cirurgia Geral da Universidade Federal do Rio de Janeiro, Rio de Janeiro, Brazil.

Journal and publication information

Publication Type: Comparative Study; Journal Article; Research Support, Non-U.S. Gov't

Journal: Anesthesia and analgesia (Anesth Analg), published in United States. (Language: eng)

Reference: 2009-Oct; vol 109 (issue 4) : pp 1312-7

Dates: Created 2009/09/18; Completed 2009/10/01;

PMID: 19762762, status: MEDLINE (last retrieval date: 10/1/2009, IMS Date: )

Sourced from the National Library of Medicine. Abstract text and other information may be subject to copyright.

External Links for this article
(including full text providers, if available):

Click Electronic Full-text Provider Links to see options for finding the electronic full text links to this article. Note there may be a subscription or fee required for access to the full text. See our FAQ for information on finding FREE full text articles.

This article may also be located in paper journal collections available in many libraries. Use the Journal and Publication Information above to find the full article.

MeSH headings (categories)

This article was linked to the MESH Headings shown below.

Male
Maprotiline - administration & dosage
Morphine - administration & dosage
Naloxone - administration & dosage
Narcotic Antagonists - administration & dosage
Pain - prevention & control
Pain Measurement
Pain Threshold - drug effects
Rats
Rats, Wistar
Reaction Time - drug effects
Serotonin Uptake Inhibitors - administration & dosage
Time Factors
Yohimbine - administration & dosage

Associated Chemicals: Adrenergic Uptake Inhibitors (0) ; Adrenergic alpha-Antagonists (0) ; Analgesics, Opioid (0) ; Antidepressive Agents, Second-Generation (0) ; Narcotic Antagonists (0) ; Serotonin Uptake Inhibitors (0) ; Maprotiline (10262-69-8) ; Yohimbine (146-48-5) ; Naloxone (465-65-6) ; Amitriptyline (50-48-6) ; Morphine (57-27-2) ; Citalopram (59729-33-8)

These are the highest related articles currently in the database: